分类: 地球科学 >> 空间物理学 提交时间: 2016-05-13
摘要: We present an experimental demonstration of edge detection based on ghost imaging (GI) in the gradient domain. Through modification of a random light field, gradient GI (GGI) can directly give the edge of an object without needing the original image. As edges of real objects are usually sparser than the original objects, the signal-to-noise ratio (SNR) of the edge detection result will be dramatically enhanced, especially for large-area, high-transmittance objects. In this study, we experimentally perform one- and two-dimensional edge detection with a double-slit based on GI and GGI. The use of GGI improves the SNR significantly in both cases. Gray-scale objects are also studied by the use of simulation. The special advantages of GI will make the edge detection based on GGI be valuable in real applications. (C) 2015 Optical Society of America
分类: 生物学 >> 生物物理学 提交时间: 2016-05-11
摘要: Enfuvirtide (T20), is the first HIV fusion inhibitor approved for treatment of HIV/AIDS patients who fail to respond to the current antiretroviral drugs. However, its clinical application is limited because of short half-life, drug resistance and cross-reactivity with the preexisting antibodies in HIV-infected patients. Using an artificial peptide strategy, we designed a peptide with non-native protein sequence, AP3, which exhibited potent antiviral activity against a broad spectrum of HIV-1 strains, including those resistant to T20, and had remarkably longer in vivo half-life than T20. While the preexisting antibodies in HIV-infected patients significantly suppressed T20's antiviral activity, these antibodies neither recognized AP3, nor attenuated its anti-HIV-1 activity. Structurally different from T20, AP3 could fold into single-helix and interact with gp41 NHR. The two residues, Met and Thr, at the N-terminus of AP3 form a hook-like structure to stabilize interaction between AP3 and NHR helices. Therefore, AP3 has potential for further development as a new HIV fusion inhibitor with improved antiviral efficacy, resistance profile and pharmacological properties over enfuvirtide. Meanwhile, this study highlighted the advantages of artificially designed peptides, and confirmed that this strategy could be used in developing artificial peptide-based viral fusion inhibitors against HIV and other enveloped viruses.